Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 8/20 | 0.53 |
| ▸ | THRA | P10827 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | ESR1 | P03372 | 2/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.51 |
| ▸ | TACR2 | P21452 | 2/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | SHBG | P04278 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.51 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL718108 | 1.00 | THRB (0.53) | THRBTHRAALDH1A1ESR1ADRA2A | |
| Ethyl Acetate SCHEMBL4477186 | 0.87 | PPARG (0.53) | THRBTHRAALDH1A1RARBMEN1 | |
| Ethyl Acetate SCHEMBL11321872 | 0.86 | PPARG (0.52) | THRBTHRAALDH1A1RARBMEN1 | |
| Acetic Acid Butyl Ester SCHEMBL6704840 | 0.84 | ALDH1A1 (0.50) | THRBTHRAALDH1A1ESR1ADRA2A | |
| SCHEMBL4252573 | 0.83 | THRA (0.55) | THRBTHRAALDH1A1ESR1ADRA2A | |
| SCHEMBL13783933 | 0.83 | ALDH1A1 (0.59) | THRBTHRAALDH1A1ESR1ADRA2A | |
| SCHEMBL19291196 | 0.83 | THRA (0.55) | THRBTHRAALDH1A1ESR1ADRA2A | |
| SCHEMBL3675245 | 0.83 | CTDSP1 (0.49) | THRBTHRAALDH1A1KDM4ELMNA | |
| SCHEMBL80498 | 0.82 | ESR1 (0.65) | ALDH1A1ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL168031 | 0.82 | ESR1 (0.65) | ALDH1A1ESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220388958-A1 | CARBAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING CARBAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2022-12-08 | — | — | US | disclosed |
| US-20200148640-A1 | CARBAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING CARBAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-05-14 | — | — | US | disclosed |
| US-20180009751-A1 | Carbazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Carbazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-01-11 | — | — | US | disclosed |
| US-9147854-B2 | Light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-29 | — | — | US | disclosed |
| US-9012894-B2 | — | — | 2015-04-21 | — | — | US | disclosed |
| US-8729310-B2 | Halogenated diarylamine compound and synthesis method thereof | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20130161593-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-06-27 | — | — | US | disclosed |
| EP-1474388-B2 | ASTAXANTHIN ESTERS | DSM IP ASSETS BV (NL) | 2013-03-06 | — | — | EP | disclosed |
| US-8324615-B2 | Light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-12-04 | — | — | US | disclosed |
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-0259085-B1 | 2-GUANIDINO-4-ARYLTHIAZOLES FOR TREATMENT OF PEPTIC ULCERS | PFIZER INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| US-5026715-A | 2-guanidino-4-arylthiazoles for treatment of peptic ulcers | PFIZER INC. (US) | 1991-06-25 | — | — | US | disclosed |
| US-4963575-A | INSECTICIDES, PESTICIDES, PARASITICIDES ANTIPROTOZOA AGENTS, NEMATOCIDES | MAY & BAKER LTD. (GB) | 1990-10-16 | — | — | US | disclosed |
| EP-0352944-A1 | Derivatives of N-phenylpyrazoles | RHONE-POULENC AGRICULTURE LIMITED (GB) | 1990-01-31 | — | — | EP | disclosed |
| CN-88103601-A | N-PHENYLPYRAZOLE DERIVATIVES | — | 1988-12-28 | — | — | CN | disclosed |
| EP-0295117-A1 | Derivatives of N-phenylpyrazoles | RHONE-POULENC AGRICULTURE LIMITED (GB) | 1988-12-14 | — | — | EP | disclosed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | disclosed |
| EP-0259085-A1 | 2-Guanidino-4-arylthiazoles for treatment of peptic ulcers | PFIZER INC. (US) | 1988-03-09 | — | — | EP | disclosed |
| CN-85109752-A | Preparation triterpenoid organic acid ester and the method that contains the hypolipidemic agents of this compounds | — | 1986-12-17 | — | — | CN | disclosed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | DDT, NAT1, CYP1A1 | THRB 1288/4885THRA 605/4885ALDH1A1 232/4885 |
| US-20220388958-A1 | CARBAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING CARBAZOLE DERIVATIVE | CRY1, AP3D1, AHR | THRB 2019/4885THRA 1399/4885ALDH1A1 133/4885 |
| US-20200148640-A1 | CARBAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING CARBAZOLE DERIVATIVE | CRY1, AP3D1, CYP1A1 | THRB 2389/4885THRA 1625/4885ALDH1A1 88/4885 |
| US-20180009751-A1 | Carbazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Carbazole Derivative | NR2E3, CRY1, AHR | THRB 2042/4885THRA 1419/4885ALDH1A1 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.